Susan Sly

Susan Sly is the Co-CEO and cofounder of RadiusAI (RAI), an award-winning visual intelligence company specializing in the retail and healthcare sectors. RAI is currently implementing its smart retail solution at the edge for a national retailer with 1,000 locations.

RAI has been named one of the fastest growing startups in Phoenix three years in a row and won VentureBeat’s AI Innovation at the Edge Award in 2022, beating out several highly acclaimed technology companies.

Prior to cofounding RAI, Susan led channel sales teams in three sectors generating over $2 billion in revenue. In her spare time, Susan is the host of the highly acclaimed podcast, Raw and Real Entrepreneurship, mom of five, wife, and tech investor. Susan has appeared on CNN, CNBC, Fox, ABC Family, and is a member of the prestigious Forbes Business Council.

Azin Radsan van Alebeek

Scarlett Spring

Anna Valcheva

Dianne Balon

Alice Zheng, MD, MBA, MPH

Lucy Perez

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy works extensively with number of biopharma and life science clients on broad range of topics, with recent focus on ESG/ sustainability, evidence generation, and digital/analytics programs to improve patient outcomes and support sustainable, inclusive growth.

Led efforts for a leading biopharma to define their ESG strategy, partnership strategy, and stakeholder engagement approach

Led efforts for a leading biopharma to embed health equity as a core principle in their R&D priorities and ways of working across the value chain

Led efforts to assess internal and external portfolio productivity and pricing models to optimize the R&D strategy and redesign the organization for a top pharmaceutical company

Led efforts for a leading biopharma to transform how it engages with customers through digital transformation, applying advanced analytics and embedding agile ways of working across their six largest markets that delivered $300M+ of near-term growth

Sponsor of McKinsey’s Early Stage Investor Conference, an annual event convening 200+ entrepreneurs and 1000+ investors interested in bio/med/health tech and sustainability innovation

Before joining McKinsey, Lucy was a research fellow at Memorial Sloan-Kettering Cancer Center, where she was involved in the development of novel treatments for solid tumors. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies. She is co-inventor on multiple patents and has published in peer-reviewed journals.